(PRESS RELEASE) AMSTERDAM, 16-Jan-2020 — /EuropaWire/ — The European Medicines Agency (EMA) appoints Dr Hilmar Hamann as Head of the Information Management Division.
Prior to joining EMA, Dr. Hamann has served as the Director for the Office of Business Informatics at the United States Food and Drug Administration (FDA). Since 2011, he has led the IT strategy and programme management for information technology and business services’ investments in support of the FDA human medicines review program. Dr. Hamann also held several leadership positions in the pharmaceutical and consumer care industry before his tenure in FDA.
Dr. Hamman, a German chemist worked in the field of molecular physics and chemical kinetics at the University of Göttingen (Germany) where he received his PhD from. Dr Hamann’s professional focus lately has been leveraging cloud-enabled technologies and robotic process automation to streamline interactions between regulatory agencies and the pharmaceutical industry.
For more information, please contact:
EMA press office
Tel. +31(0)88 781 8427
E-mail: press@ema.europa.eu
SOURCE: European Medicines Agency
(IN BRIEF) Saltigo, a subsidiary of LANXESS specializing in exclusive synthesis of active ingredients and…
(IN BRIEF) FORVIA, the world’s seventh-largest automotive technology supplier resulting from the merger of Faurecia…
(IN BRIEF) German MAWS GbR, comprised of ESG Elektroniksystem- und Logistik-GmbH, HENSOLDT Sensors GmbH, and…
(IN BRIEF) VARTA AG's Supervisory Board has named Michael Ostermann as Board Member and Chief…
(IN BRIEF) Ericsson and Umniah have inked a memorandum of understanding (MoU) to extend the…
(IN BRIEF) VINCI Highways, a subsidiary of VINCI Concessions, secures contracts in Georgia and Texas,…